Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Clinical trial NCT04057703 · COMPLETED

Trial details

NCT number: NCT04057703
Sponsor: University Hospital, Bordeaux
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Thrombocytopenic Purpura Autoimmune Hemolytic Anemia Evan Syndrome Immunotherapy

Start date: 2016-01-18
Primary completion: 2016-12-04
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.